|
Characteristic
|
Patients
|
|---|
| |
(N = 72)
|
|---|
|
Age, years
| |
|
Median (SD)
|
58.0 (12.4)
|
|
Range
|
23–78
|
|
Gender, n (%)
| |
|
Male
|
36 (50.0)
|
|
Female
|
36 (50.0)
|
|
ECOG PS, n (%)
| |
|
0
|
22 (31)
|
|
1
|
49 (68)
|
|
Not recorded
|
1 (1)
|
|
Tumor type, n (%)
| |
|
NSCLC
|
13 (18.0)
|
|
Breast
|
10 (13.8)
|
|
Melanoma
|
6 (8.3)
|
|
Pancreas
|
5 (6.9)
|
|
Prostate
|
4 (5.6)
|
|
Colon
|
4 (5.6)
|
|
Esophagus
|
3 (4.2)
|
|
Parotid
|
3 (4.2)
|
|
SCLC
|
3 (4.2)
|
|
Othera
|
21 (29.2)
|
- Abbreviations: SD standard deviation, ECOG Eastern Cooperative Oncology Group, PS performance status, SCLC small cell lung cancer, SCC squamous cell cancer.
- aCervical, cholangiocarcinoma, gastric, mesothelioma, endothelial cell, bladder, renal, sarcoma, SCC orbit, SCC vagina, SCC vulva, anal, tonsil, hard palate, and vulva.
